Effect of targeting normal fasting glucose levels with basal insulin glargine on glycaemic variability and risk of hypoglycaemia: a randomized, controlled study in patients with early Type 2 diabetes-Reference-Cited by-同舟云学术

Effect of targeting normal fasting glucose levels with basal insulin glargine on glycaemic variability and risk of hypoglycaemia: a randomized, controlled study in patients with early Type 2 diabetes

Published:2010-02 Issue:2 Volume:27 Page:175-180
ISSN:0742-3071
Container-title:Diabetic Medicine
language:en
Short-container-title:

Author:

Hanefeld M.,Koehler C.,Hoffmann C.,Wilhelm K.,Kamke W.,Gerstein H.

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-5491.2009.02915.x/fullpdf

Reference21 articles.

1. Diabetes and cardiovascular disease: explaining the relationship;Punthakee;Rev Cardiovasc Med,2007

2. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. European Diabetes Epidemiology Group. Diabetes Epidemiology: collaborative analysis of diagnostic criteria in Europe;The DECODE Study Group;Lancet,1999

3. Blood glucose and risk of cardiovascular disease in the Asia Pacific region;Lawes;Diabetes Care,2004

4. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes;Patel;N Engl J Med,2008

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of intensive versus conventional glucose targets in people with type 2 diabetes: a systematic review and meta-analysis;Expert Review of Endocrinology & Metabolism;2023-01-02

2. Marine-derived n-3 fatty acids therapy for stroke;Cochrane Database of Systematic Reviews;2022-06-29

3. Influence of Fasting Plasma Glucose Targets on Glycemic Variability in Chinese Participants With Type 2 Diabetes: A Post Hoc Analysis of the FPG GOAL Trial (BEYOND III);Advances in Therapy;2021-11-10

4. Fasting Glucose of 6.1 mmol/L as a Possible Optimal Target for Type 2 Diabetic Patients with Insulin Glargine: A Randomized Clinical Trial;Journal of Diabetes Research;2021-07-14

5. Coronary Flow Reserve and Glycemic Variability in Patients with Coronary Artery Disease;Internal Medicine;2021-04-15